Category Archives: EP and UK Practice

Australia: Cancer Voices v Myriad Opinion Affirmed

Posted on September 5, 2014 by Warren Woessner

This is a guest post from Paul Cole. An opinion was handed down earlier today by the Federal Court of Australia – Full Court (Allsop C.J., Downsett, Kenny, Bennett and Middleton J.J., D’Arcy v Myriad Genetics Inc [2014] FCAFC 115 … Continue reading →

Posted in EP and UK Practice | Tagged biotechnology law, EPO, intellectual property, ip, Myriad, Patent Law, patents, Paul Cole, Warren Woessner | 2 Comments

EPO Abolishes Prior “Short” Divisional Guidelines

Posted on October 21, 2013 by Warren Woessner

This is a guest post from Mewburn Ellis of London. The Administrative Council (the governing body of the European Patent Office) has decided at its meeting on 16 October 2013 to change the regulations regarding the deadline for filing divisional … Continue reading →

Posted in EP and UK Practice | Tagged biotechnology law, EPO, intellectual property, ip, Mewburn Ellis, Patent Law, Warren Woessner | Leave a comment

Case Law of the EPO Boards of Appeal Released

Posted on October 10, 2013 by Warren Woessner

Thanks to correspondent Paul Cole of Lucas &Co. for sending us the below notice. Students of patent law will welcome the 7th edition of this well-known compilation which went live on the EPO website on 4th October. It is now … Continue reading →

Posted in EP and UK Practice | Tagged Appeal Board, EPO, Paul Cole, USPTO, Warren Woessner, Wim van der Eijk | Leave a comment

Common Patent for European Union Adopted

Posted on December 12, 2012 by Warren Woessner

The European Union has finally decided to adopt a common patent that will be granted in three languages – English, French and German – but will cover all of the 27 EU countries. Note that there is not a perfect … Continue reading →